Epicore Biosystems – a digital health solutions leader developing advanced sweat-sensing wearables – announced that it has raised $26 million in Series B funding led by the Steele Foundation for Hope (SFFH).
This funding will help Epicore drive global adoption of its personalized hydration and cloud analytics platform and expand into new biomarker targets relevant to kidney health, women’s health, malnutrition and environmental toxin exposures.
Excessive heat exposure causes significant global challenges, especially for individuals at the highest risk of heat injury, such as industrial workers, children, and expecting mothers. And the threat of heat and the compounding effects of environmental toxins have been shown to result in acute health risks and chronic conditions at alarming rates.
Epicore tackles these challenges with its sweat-sensing solutions, which offer real-time insights into hydration, stress, nutrition, and wellness. Epicore’s technology taps into the underlying biochemistry and metabolic health by measuring sweat composition and fluid losses noninvasively and in tandem with traditional digital biomarkers to alert when a wearer is at risk of heat injury, dehydration, or malnutrition.
Epicore’s suite of sweat-sensing wearable solutions includes the Gx Sweat Patch, which is commercialized in partnership with PepsiCo and Gatorade, the Discovery Patch Sweat Collection System (FDA Class I device), and the Connected Hydration wearable and cloud platform tailored for industrial workers.
Since completing the Series A funding round over three years ago, Epicore has expanded beyond sports and fitness and grown its customer base by 24 times with leading multinational enterprises in the energy, construction, manufacturing, and aviation sectors. With ever-growing health and environmental disparities, the need for connected digital solutions that measure advanced biometrics and provide personalized recommendations is driving a new health tech revolution.
KEY QUOTES:
“Epicore has developed a new class of biochemical sensing wearables that enable the sports, fitness and connected worker sectors to unlock key health and wellness insights. Our technology delivers data-driven recommendations to the wearer to help manage these types of challenges. The Series B investment will help expand our global reach and accelerate the validation of new biomarkers needed to shape the future of personalized hydration and wellness strategies for all.”
- Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems
“Epicore’s commitment to improving personalized health for those in critical need aligned strongly with our mission to improve the quality of life for people in need worldwide. We are proud to back Epicore’s pioneering work in sweat-monitoring technology, an innovation with significant potential to address the critical health challenges frontline populations face due to climate change.”
• ⁃ Joe Exner, CEO of Steele Foundation for Hope
